Publikationen

Christoph F, Koenig F, Lebentrau S, Jandrig B, Krause H, Strenziok R, Schostak M. „RANKL/RANK/OPG cytokine receptor system: mRNA expression pattern in BPH, primary and metastatic prostate cancer disease“. World J Urol, 2018 Feb;36 (2):187-92. Epub 2017 Dec 4.

Strenziok R, Hinz S, Wolf C, Conrad T, Krause H, Miller K, Schrader M. „Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: serum protein profiling in seminoma patients“. World J Urol, 2010 Apr;28 (2):193-7. Epub 2009 Jun 16.

Wolf C, Strenziok R, Kyriakopoulos A. “Elevated metallothionein-bound cadmium concentrations in urine from bladder carcinoma patients, investigated by size exclusion chromatography-inductively coupled plasma mass spectrometry”. Anal Chim Acta, 2009 Jan;631 (2):218-22. Epub 2008 Nov 1.

Kempkensteffen C, Hinz S, Jäger T, Weikert S, Krause H, Schostak M, Christoph F, Strenziok R, Miller K, Schrader M. „Expression levels of the IAP antagonists XAF1, Smac/DIABLO and HtrA2 in testicular germ cell tumours“. Aktuelle Urol, 2008 Nov;39 (6):436-41. Epub 2008 Oct 31.

Christoph F, Strenziok R, Hinz S, Lenz D, Miller K, Schrader M. „Detection of new candidate genes for gene promoter analysis performing genome wide expression analysis with the affymetrix U133A 2.0 human gene chip“. Eur Urol Suppl, 2008 Mar;7 (3):208.

Lingnau A, Strenziok R, Krause H, Christoph F, Koellermann J, Miller K, Schostak M. „Decreased mRNA expression of ING1 and ING4 tumour suppressor genes in prostate cancer and analysis of promoter methylation“. Eur Urol Suppl, 2008 Mar;7 (3):142.

Schostak M, Braun C, Krause H, Miller K, Kempkensteffen C, Hinz S, Strenziok R, Blana A, Schrader M. „Neue Polymorphismen im PSA-Promoter bei Prostatakrebs“. Aktuelle Urol, 2007 Nov;38 (6):465-72.

Glanemann M, Strenziok R, Kuntze R, Münchow S, Dikopoulos N, Lippek F, Langrehr JM, Dietel M, Neuhaus P, Nussler AK. „Ischemic preconditioning and methylprednisolone both equally reduce hepatic ischemia/reperfusion injury“. Surgery, 2004 Feb;135 (2):203-14.